Ventricular Sigmoid Septum as a Risk Factor for Anthracycline-Induced Cancer Therapeutics-Related Cardiac Dysfunction in Patients With Malignant Lymphoma

Background: Identifying risk factors for cancer therapeutics-related cardiac dysfunction (CTRCD) is essential for the early detection and prompt initiation of medial therapy for CTRCD. No study has investigated whether the sigmoid septum is a risk factor for anthracycline-induced CTRCD. Methods and ...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Takafumi, Oshima, Yoshiko, Shintani, Yasuhiro, Yamamoto, Junki, Yokoi, Masashi, Ito, Tsuyoshi, Wakami, Kazuaki, Kitada, Shuichi, Goto, Toshihiko, Hashimoto, Hiroya, Kusumoto, Shigeru, Sugiura, Tomonori, Iida, Shinsuke, Seo, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2022
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977195/
https://www.ncbi.nlm.nih.gov/pubmed/35434414
http://dx.doi.org/10.1253/circrep.CR-21-0145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977195/
https://www.ncbi.nlm.nih.gov/pubmed/35434414
http://dx.doi.org/10.1253/circrep.CR-21-0145

Ejemplares similares